News
By John Vandermosten, CFA NASDAQ:BCTX READ THE FULL BCTX RESEARCH REPORT Second Quarter Fiscal Year 2022 Operational and Financial Results On March 16th 2023, BriaCell Therapeutics Corp. (NASDAQ ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback